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A NOTE FROM ROSS HALL
Welcome to our Spring 2017 edition. I am incredibly proud of our students and trainees. They are a diverse, altruistic, 
exceptionally bright group who came to the George 
Washington University (GW) School of Medicine and Health 
Sciences (SMHS) to grow professionally and personally. Now, 
as we prepare to transition from one academic year to the next, 
I want to congratulate our outstanding graduates. I am proud 
of everything they have accomplished.
I’ve always felt enormous pride in being an alumnus and 
faculty member of SMHS. No, we don’t have a football team, 
and our sports teams don’t always draw national attention. 
However, I know that I received a great medical education and 
residency training at GW. And as dean, I know that we have 
an amazing group of talented and dedicated faculty and staff. 
I am unbelievably proud of them and the work that they do 
to make a difference in our students’ and patients’ lives; in the 
community; and, by advancing knowledge, in medicine at large. 
The school’s reputation for creating tomorrow’s health 
professionals, advancing research, providing high-quality 
care, and effecting change in our local, national, and global 
communities has never been higher. When you read these 
stories touching on each aspect of our mission, I hope you share 
the same sense of pride as our students. 
As the university moves closer to completing its Making 
History fundraising campaign, and as President Steven Knapp 
concludes his tenure here, I hope that your pride in SMHS 
leads you to make a gift to support our mission of being a 
world-class academic medical center. Our students and faculty 
who benefit from your philanthropy will be eternally grateful.
JEFFREY S. AKMAN, M.D. ’81, RESD ’85
VICE PRESIDENT FOR HEALTH AFFAIRS 
WALTER A. BLOEDORN PROFESSOR OF ADMINISTRATIVE MEDICINE 
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MFA Welcomes New CEO
George Washington University (GW) Medical Faculty 
Associates (MFA) recently selected Robert E. Kelly, M.D., to 
serve as CEO of the clinical enterprise. In this role, he will 
provide leadership and strategic physician enterprise inte-
gration, as well as overall operational management for the 
organization. Kelly brings to GW decades of both clinical and 
administrative experience, most recently serving as presi-
dent and chief operating officer of New York-Presbyterian 
Hospital, and as a faculty member of Weill Cornell College of 
Medicine since 1985.
As CEO, Kelly will partner with Anton Sidawy, M.D., 
M.P.H. ’99, president and chair of the Board of Trustees at the 
GW MFA, and Lewis B. Saltz Professor and Chair of Surgery 
at the GW School of Medicine and Health Sciences, and 
other key members of the GW MFA community to further 
develop and implement the organization’s mission and stra-
tegic vision.  
Lt. Gen. West  
Addresses Graduates
Lt. Gen. Nadja West, M.D. ’88, will 
serve as keynote speaker at the George 
Washington University School of 
Medicine and Health Sciences M.D. 
program diploma ceremony on May 21.
West is the 44th surgeon general 
of the United States Army and 
commanding general, U.S. Army 
Medical Command. 
She has served in a variety of lead-
ership positions and has commanded 
at the Army Community Hospital, Army 
Medical Center, and Regional Medical 
Command levels. Before being named 
surgeon general, she served as the U.S. 
Joint Staff surgeon.
West will receive an honorary 
degree of doctor of public service at 
GW’s 2017 Commencement on the 
National Mall.  
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Match Day
1  Marcus Mitchell welcomes an embrace 
after learning he has matched in his top 
choice for anesthesiology: the University 
of Maryland Mercy Medical Center and 
Johns Hopkins Hospital. 
2  Olivia Beaubrun, left, and Theiju 
Sebastian, right, smile for the camera after 
opening their envelopes to see where 
they’ve matched: St. Louis Children’s 
Hospital and Yale University New Haven 
Hospital, respectively. “This is way more 
emotional than I could’ve imagined,” said 
Sebastian, who matched in pediatrics, as 
did Beaubrun. “It’s the best day ever.”
3  Cristina Zottola, right, who matched in 
obstetrics and gynecology at Lenox Hill 
Hospital with Hofstra Northwell School 
of Medicine, laughs at the reaction from 
family and friends after showing them her 
letter.
Follies
4  Fourth-year medical students bid Auf 
Wiedersehen — with lyrics tweaked to 
better suit a medically inclined audience 
— during Follies, the annual student-run 
program of skits, dances, and songs.
5  The M.D. Class of 2017 celebrates the 
end of their final Follies with an eye toward 
the future: the institutions where they will 
complete their residencies. 
6  Third-year M.D. students Christina 
Canini, left, and Omid Manoochehri, 
right, have a spirited debate over Suzanne 
Arnott, who awaits a decision. 
Day in the Life
7  First-year medical student — but almost 
a doctor! — Vinay Rao stands with his family 
at the kickoff to “Day in the Life,” a bien-
nial event when M.D. students’ family and 
friends participate in a white coat cere-
mony, interactive sessions and discussion 
groups, and a diploma ceremony.
8  Juliet Lee, M.D., assistant professor 
of surgery at SMHS, helps an SMHS 
family member perform proper CPR 
technique during “Code Blue,” one of 
several sessions offered to Day in the Life 
participants.
9  Day in the Life participants get a true 


























On the second day of the 22nd annual 
George Washington University (GW)
Research Days, School of Medicine and 
Health Sciences (SMHS) students had a 
chance to show off their work outside 
the classroom to their peers and the 
GW community.
“That’s the fun part [of Research 
Days],” second-year M.D. student 
Sharjeel Chaudhry said of seeing his 
classmates’ research projects. “It’s a 
Putting Health Care on Center Stage: 
Standing on the stage in George Washington University’s 
(GW’s) Jack Morton Auditorium in February, Sens. Bernie 
Sanders (D-Vt.) and Ted Cruz (R-Texas) debated the state of 
the U.S. health care system.
Although the lawmakers did not agree on much 
throughout the debate, they were able to have a frank and 
open discussion about the Affordable Care Act’s future.
“It was nice and refreshing for neither side to be yelling, 
but simply stating the facts and their positions,” said John 
Marin, a first-year M.D. student at GW. “I definitely appre-
ciate GW holding all these talks.”
During the almost two-hour debate, Cruz and Sanders 
spoke about the role of the government in health care and 
the future of Medicare.
great way to make a new connection, 
just from understanding someone’s 
research and talking with them 
about it.”
Chaudhry presented his work as 
a winner of the William H. Beaumont 
Research Award, as did first-year 
M.D. students Brendan Campbell 
and Lauren Jacobs. The new tradi-
tion began last year when the editors 
of Fusion, the William H. Beaumont 
Medical Research Honor Society’s 
student-led publication, decided 
to give students the opportunity to 
present their research. 
In addition, more than 200 
SMHS students presented posters at 
the event. 
To download a copy of the most 
recent edition of Fusion, visit smhs.gwu.
edu/research/publications/fusion.  
Research Days Showcase Breadth and Depth of Student Endeavors
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Service and Leadership
Sara Melita was recently selected to serve as the senior 
advisor and chief of staff to Jeffrey S. Akman, M.D. ’81, RESD 
’85, vice president for health affairs, Walter A. Bloedorn 
Professor of Administrative Medicine, and dean of the GW 
School of Medicine and Health Sciences (SMHS). In her new 
role, she’ll work with the SMHS senior leadership team to 
advance Akman’s vision and priorities for the school.
Melita brings 20 years of senior leadership and advisory 
experience to the post, a decade of which has come at 
GW. In that time, she served as the assistant vice presi-
dent for organizational development and effectiveness, 
where she focused on building effective teams 
and improving performance throughout GW. More 
recently, she was a senior advisor to GW’s senior lead-
ership team, working across schools and divisions to 
develop annual and strategic goals aligned with mission 
priorities. She also was involved in the development and 
implementation of GW’s Vision 2021 Strategic Plan.  
Taking Home the Golden Apple
Every year, medical and physical therapy students vote on 
the educators who have had a significant impact on their 
education; the 2017 Golden Apple Award recipients were 
Zhiyong Han, Ph.D., associate professor of biochemistry and 
molecular medicine; Marie Almira-Suarez, M.D., assistant 
professor of pathology; Kristin Gorelik, M.D., 
assistant professor of obstetrics 
and gynecology; Kathleen 
Calabrese, M.D. ’08, assistant 
professor of emergency 
medicine; Holly Jonely, 
D.P.T., assistant professor 
of physical therapy and 
health care sciences; and 
Margaret Plack, D.P.T., 
Ed.D., professor of physical 
therapy and health care 
sciences.  
THE CAMPAIGN FOR GW
SCHOOL OF MEDICINE &
HEALTH SCIENCES
Support the School 
of Medicine &
Health Sciences
By advancing our four-part mission — to teach, heal, 
discover, and serve — GW’s School of Medicine and 
Health Sciences (SMHS) seeks to change lives and 
advance society.
SMHS is part of the George Washington University‘s 
$1 billion philanthropic campaign, which supports 
students, enhances academics, and breaks new 
ground through capital projects and research. 
Your gift enables SMHS to have an impact in the 
community, the country, and the world.
Join us in making history
go.gwu.edu/makehistorysmhs
Capital campaign_4617.indd   1 4/6/17   9:25 AM
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UNDER A  
NEW UMBRELLA
BY CAROLINE TRENT-GURBUZ B rent Etiz, a Stanford graduate and former Silicon Valley techie, was in need of a change. “I had this period of enlightenment,” he says, “where I thought ‘I really want to go back and try [becoming a doctor],’ 
so I started scouring the country for programs that offered all 
of the premedical requirements.” The George Washington 
University (GW) School of Medicine and Health Sciences 
(SMHS) Post-Baccalaureate Pre-Medicine program fit the bill.
The program, designed to prepare college graduates with 
the prerequisites for admission, has long attracted highfliers 
like Etiz, successfully guiding them into medical school. 
Likewise, another SMHS program, Medical Laboratory 
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Sciences (MLS) — a combination of 
blended (a mixture of online and bricks-
and-mortar courses) and graduate 
programs — has drawn ambitious 
students interested in ascending to the 
next step in their career.
“I love the program,” says Brandy 
Holzman, an MLS student. After 
riding in a hunter/jumper horse show 
circuit until she was 28, Holzman felt 
she “needed to find a career that doesn’t 
involve horses.” Tired of traveling and 
suffering from back pain, she began 
working in an animal hospital, with an 
eye toward shifting to the human side of 
health care. “I felt too old [for medical 
school], so this [program] was a nice 
balance; I can be well-rounded and help 
with the diagnostic work and still talk to 
doctors. It seemed like a good fit for me.”
With the success of the MLS and 
Post-Baccalaureate Pre-Medicine 
programs — both of which fell under 
the Clinical Research and Leadership 
umbrella within Health Sciences — came 
expansion. When GW started to build 
out the Virginia Science and Technology 
Campus (VSTC) in Ashburn, Virginia, 
an opportunity presented itself: The 
two programs were shuffled under the newly established 
Department of Integrated Health Sciences, led by interim chair 
Marcia Firmani, Ph.D., M.S.P.H., and relocated to the VSTC.
“We’re able to have dedicated staff at the VSTC to advise 
on these programs and have people doing outreach specifically 
for these programs,” says Firmani, who also serves as director 
of the MLS blended bachelor of science in health sciences 
(B.S.H.S.) and graduate programs and as assistant professor 
of integrated health sciences at SMHS. “For everyone in the 
department, their home is at VSTC. The benefit is, we now 
have that common ground that provides better opportunities to 
work together to expand the existing programs while building 
new programs.”
The new department also includes distance-learning 
opportunities — a fully online B.S.H.S. with a major in MLS for 
medical lab technicians, five certificate programs, five graduate 
programs, and numerous military-affiliated programs — and 
future educational possibilities.
“We’re in the process of developing dual-degree programs, 
and we are in the planning stages of a potential doctoral degree 
program to expand upon our current career pathway options 
at VSTC,” Firmani says. “There are a lot of opportunities for 
growth, teamwork, and spearheading new endeavors, which is 
an exciting movement to be involved in.”
Holzman says that having access to the VSTC campus for 
her program, which blends online coursework with on-site lab 
training, has been ideal. “I was scared at first, because I’ve never 
done online courses, but it’s worked out well,” she says. “Having 
a lab in Ashburn is great because I still have that contact 
between professor and student.” 
Kenia Gomez, who’s in her last semester in the blended 
MLS program, has also found that the class structure suits her 
needs. “What I like about the program is that the laboratory 
class covers the same material being taught online,” she 
explains. “[It] helps me understand the course material and the 
science behind it more.”
Etiz, when he’s not preparing for the MCAT with his 
cohort, has also taken advantage of what the VSTC offers. 
“Because there’s the MLS program, there’s also a research 
laboratory out of the Virginia campus, so I had the opportunity 
to assist in research with Dr. Marcia Firmani,” he says. “To 
be able to have those opportunities while also completing my 
didactic work … ultimately made coming to GW a very easy and 




n August 2016, members of the George Washington 
University (GW) Hospital anesthesia team — including 
Samantha Brackett, who was just one month into her 
first year of residency — were waiting on standby in the 
interventional radiology (IR) suite. Their patient had presented 
to the Emergency Department with severe abdominal pain, but 
was stable enough to move to the IR suite for a procedure to 
embolize a ruptured vessel, the source of the problem.
Suddenly, recalls Brackett, “the patient experienced an 
acute intra-abdominal hemorrhage from the rupture of this 
vessel, and became very unstable. We were immediately able 
to secure the airway as well as manage the massive blood 
loss and critical situation that was unfolding. Immediately 
after intubating, I began to notice certain changes that are 
characteristic of MH.”
Brackett explains in lay terms that MH, or malignant 
hyperthermia, is a rare genetic disorder that causes a defect in 
a type of skeletal muscle receptor. When certain anesthetic 
agents, such as inhaled anesthetics and succinylcholine, a 
neuromuscular blocking drug, interact with the receptor, a 
biochemical chain reaction occurs.
BY CAROLINE TRENT-GURBUZ
“[The body] generates excessive heat that actually breaks 
down the muscle cells,” Brackett explains. “You can have 
pretty catastrophic damage. It’s key that you treat it early, 
and even minutes in treatment delay will increase morbidity 
and mortality.”
With the clock ticking, Brackett noted key signs of the 
disorder — increased exhaled carbon dioxide, increased heart 
rate and temperature, and muscle rigidity — and ran through 
the checklist of possible diagnoses in her head. The habit was 
one she had performed during an MH simulation just a few 
days earlier in the Clinical Learning And Simulation Skills 
(CLASS) Center at the GW School of Medicine and Health 
Sciences (SMHS) — a striking coincidence given that most 
anesthesiologists never see MH in their entire career, let alone 
within the first weeks of their residency.
“In all of the years I’ve been practicing, getting close to 20 
years, I’ve never had a patient with MH, ever — that’s how rare 
it is,” says Marian Sherman, M.D. ’99, assistant professor of 
anesthesiology and critical care medicine at SMHS. “But you 
talk about it every year in training, you talk about it on every 
standardized exam you ever take as an anesthesiologist. It’s 
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definitely one of those clinical scenarios that’s high stakes, and 
you’d better know what to do with it because it’s our specialty.”
It’s for those reasons that anesthesiologists regularly train 
for cases like MH. For residents, however, simulating such 
a critical disorder not only incorporates minor simulation 
exercises, such as inserting an IV or arterial line, but also team 
training and communication skills. 
“When you’re doing high-stakes drills, like an MH drill, you 
don’t want one person doing everything,” Sherman says. “You 
want one person to lead the drill, you want to recognize people’s 
skills and abilities and assign tasks to each person, and create 
conversation between the participants so that you can intervene 
most comprehensively in these crises. As always, the earliest 
determination of what’s wrong relates to better patient outcome.”
It’s that type of training in which the SMHS CLASS 
Center excels. “You learn better when you do it yourself,” says 
Claudia Ranniger, M.D., Ph.D., director of the simulation 
center and assistant professor of emergency medicine at SMHS, 
“and we don’t let you leave having failed.”
What’s key, both Ranniger and Sherman say, is that the 
CLASS Center is a safe learning environment. Depending on 
the scenario, both residents and medical students, as well as 
nurses from GW Hospital, can practice their skills — whether 
with manikin Victoria in the labor and delivery suite; with 
another manikin, Hal, in one of two operating rooms; or in the 
high-fidelity rooms and the procedural skills lab — without 
worrying about negatively affecting patient outcomes. 
“It’s great to have a responsibility that you usually don’t get to 
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practice and to test yourself in a safe environment,” Ranniger says.
Rooms are set up as realistically as possible, with the 
kind of equipment students and residents would see in GW 
Hospital. Depending on the scenario, learners may know 
various details and operate accordingly; in other cases, students 
will go in without any information. 
“The subject matter almost gives away what’s important in 
the exercise, which is identifying variables and coming up with a 
broad differential diagnosis, and then making smart, informed 
interventions,” Sherman says. “We might give them a little bit of 
information, like ‘the patient you’re taking care of is a 40-year-old 
person who has a history of asthma and had a knee scope under 
epidural anesthesia in the past. You’re taking care of this patient 
now. The patient’s in the OR, ready for induction of anesthesia.’ ”
From left to right, Marian Sherman, M.D.; 
Asheesh Kumar, M.D.; Marianne David, M.D.; 
Samantha Brackett, M.D.; Raymond Pla, M.D.; 
and Hank Allen, M.D.
In Brackett’s simulation, there was scant contextual 
information. “We knew that the scenario would involve a type 
of anesthetic crisis; we just didn’t know what type of emergency 
we were going to deal with,” she recalls. “Our scenario involved 
a young, healthy patient having a fairly low-risk surgical 
procedure. The case began at the time of induction of general 
anesthesia in the operating room.”
It was then that she ran through possibilities in her head, 
an ability that was strengthened with practice. “What, in 
particular, the anesthesiologists do when they ‘sim’ with their 
residents, is to say ‘come up with a differential diagnosis in your 
head for all the things it could be, no matter how improbable,’ ” 
Ranniger explains. “Unless you do that, you won’t think of 
it when it really happens. It keeps you engaged in care of 
the patient and thinking ahead, and that’s really what’s so 
important to prevent adverse outcomes: to see it coming, not 
wait until it happens and recognize it.”
With her simulation team, Brackett considered potential 
diagnoses before settling on the correct one and shifting to 
the debriefing session, arguably the most important part of the 
simulation exercise. Because the CLASS Center simulation 
rooms are equipped with audio and video recording, debriefing 
participants can review their performance, learn the consequences 
of misdiagnosis, and reflect on their diagnostic process.
“There’s no better way to learn than to have followed 
your line of thinking and get the wrong clinical consequence, 
because every single simulation session we do is followed 
immediately by a debriefing session,” Sherman says. “Some 
people have an image of what they look like or what they’re 
doing in a scenario, but if they’re anxious and they’re hanging 
back, you can see that when you do the video recap. A simple, 
gentle suggestion like ‘move in next time’ [works] because when 
you’re in closer to the patient, the whole team knows you’re 
there, your hands are ready to work.”
That kind of encouragement directly feeds into students’ 
and residents’ performance when in a real-world situation. In 
Brackett’s case, as the team tackled their patient’s care in the 
IR suite, she mentally ran through the differential diagnoses, 
“picking it up, I think immediately, because I had in the back of 
my head that I had just experienced it and I knew it was such a 
potentially devastating diagnosis.”
Brackett relayed her suspected diagnosis to the other 
anesthesiologists, an act of considerable courage. “For a first-
year resident to say ‘I think this patient’s resuscitation might be 
complicated by a case of MH’ [was brave] — she said it a couple 
of times, and I really applaud her for having the confidence to 
say again that something isn’t right here,” Sherman notes. 
Brackett, however, credits the diagnosis to her team. “I 
had such a strong team around me,” she says. “That definitely 
put me at ease, and we were able to effectively communicate 






eamer L. Bushardt, Pharm.D., P.A.-C., DFAAPA, 
brings a wealth of expertise to his role as senior 
associate dean for health sciences at the George 
Washington University (GW) School of Medicine 
and Health Sciences (SMHS). Bushardt is both a pharmacist 
and a physician assistant (P.A.) with experience in caring for 
underserved communities in rural areas of the Carolinas. 
Bushardt earned a degree in pharmaceutical sciences and 
a doctor of pharmacy from the University of South Carolina. 
After practicing as a pharmacist in a cancer center, he trained 
as a physician assistant at the Medical University of South 
Carolina and practiced in rural primary care. Bushardt began 
his career in academic medicine in the Palmetto State, but 
he is no stranger to Washington, D.C. He serves as editor-in-
chief for the Journal of the American Academy of Physician 
Assistants ( JAAPA), based in Alexandria, Virginia. Bushardt 
says he regularly spent time between meetings learning about 
and exploring the District.
“Through my editorial work and as a visiting scholar, I 
met some of the faculty at GW, and I was really attracted to 
the breadth and depth of their talents,” he says. “I’ve also had 
a very strong interest in learning more about health policy and 
about the innovative ways we can train health professionals 
and health care researchers — [areas where] the GW 
community is very much at the forefront.” 
Although Bushardt is still setting up his office in Foggy 
Bottom and adjusting to life in D.C., his vision for the future 
of the dozens of health sciences academic programs at SMHS 
is already forming. Here, he discusses his career path from 
pharmaceutical science to higher education and his aspirations 
for health sciences at GW.
Q: What is your vision for the future of health sciences at GW?
A: A vision for the future of health sciences is not 
something I needed to create. It already lives within the 
faculty, staff, and students across the health sciences programs. 
My job is to help them realize their strengths and come 
together as a diverse family of health sciences researchers 
and educators. Health sciences hosts 45 different academic 
BY KATHERINE DVORAK
programs, and many are unique with regard to curricula and 
program goals. Our health sciences students experience GW 
very differently — some as residential learners in Foggy Bottom 
or at the Virginia Science and Technology Campus (VSTC), 
others from all over the world in online learning communities, 
some within postgraduate programs in various hospital and 
health systems, or even during active military service via 
educational partnerships with the U.S. military. There is no 
one educational paradigm for health sciences. 
My challenge is to build a shared identity that leverages 
our collective strengths. This challenge calls us to prioritize 
and even more fully embrace interprofessionalism as a 
value across every facet of what we do. It is about advancing 
translational research and pioneering new and innovative ways 
to prepare health care professionals. It is taking our combined 
knowledge from practice, from policy, from research, from 
public health, and from the classroom, and creating an 
inventive approach to reach our goals — an approach that is 
distinctively health sciences. 
I really enjoy breaking silos and bringing together talent in 
ways it might not naturally combine, so I am beyond excited to 
be here at GW. 
Q: What drew you to pharmacy? 
A: Mentoring and apprenticing drew me to pharmacy. 
My father is a community pharmacist and leader in that 
profession, particularly in South Carolina. He worked for 
40 years as a small-business owner. At age 10 or 11, I started 
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helping him in his drugstores. I loved the atmosphere. My 
father is such a warm and incredibly kind person. He forged 
incredible relationships with his patients, and humbly worked 
behind the scenes to help them solve problems that got in the 
way of healthier, productive lives. I aspired to be like him (I 
still do, actually). My professional identity as a pharmacist 
started forming well before I attended my first pharmacology 
or therapeutics class. 
Q: After earning your Pharm.D., you went on to train as a P.A. 
What interested you in the P.A. profession? 
A: My first job as a pharmacist was in a cancer center in 
South Carolina, primarily working with socioeconomically 
disadvantaged patients with cancer. There was a small group 
of oncologists, and I was a clinical pharmacist embedded 
with that team. I would support patients who developed 
adverse effects to treatment or who were balancing chronic 
medical issues along with their treatment for cancer. This 
partnership with physicians and with patients felt very natural. 
My physician colleagues were very focused on trying to cure 
the patients from their cancer, and they welcomed my help 
to address adverse effects or chronic medical illnesses. After 
doing that for a little while, I wanted to advance my diagnostic 
skills, and the P.A. profession really spoke to me. It offered me 
what I felt I needed. 
Q: Recently a new health sciences department was created at 
the VSTC — the Department of Integrated Health Sciences. Do you see 
more growth at VSTC in the future?
A: The VSTC is an incredible asset for the university and 
region. This campus is a focus for much of our targeted growth 
in health sciences. The synergy realized between schools with 
VSTC-based programs is excellent. The School of Medicine 
and Health Sciences has strong collaborations with the College 
of Professional Studies and the College of Nursing, which both 
maintain strong contingencies there as well. 
As a newcomer to GW, I am thrilled to have the 
opportunity to work in Northern Virginia, which is 
surrounded by leading companies and forward-thinking 
industries in technology and data management. The health 
sciences team regularly meets with dynamic industry 
executives there to learn about how their fields are evolving; to 
talk with them about partnerships in workforce development 
and innovation; and to explore new professions and lines of 
study that can continue to stimulate advances in education, 
research, and service. We are not trying to reinvent any wheels. 
If you want to transform discoveries into products and services 
that benefit society, then cultivating meaningful partnerships 
between higher education and industry is the right move. 
Q: What got you interested in being editor-in-chief of JAAPA?
A: I’ve always enjoyed writing. One of my grandmothers 
was an English teacher, and during elementary and middle 
school, I would go after school to spend time with my 
grandparents. My grandmother would help me with my 
homework, with special attention for any writing assignments. 
She loved a red pen like any good English teacher, and I can 
still see her fine, red cursive tightly positioned between my 
original lines. Inadvertently, she offered me this boot camp 
experience in writing. 
When I took my first job in academia at the Medical 
University of South Carolina as a … faculty member, I was 
thrust into this space where writing grants and scholarly 
articles was an expectation, and I enjoyed it. … I started peer 
reviewing and writing for JAAPA, and the editor asked if I 
would consider being a regular writer and part of the editorial 
board, so I did that. When the editor-in-chief retired several 
years later, I was approached about taking that position.
Q: What made you decide to pursue a career in academic 
medicine, and what does it mean to you to play a role in the 
education of future medical professionals?
A: Growing up in a rural, underserved community shaped 
that desire. In my hometown, there were limited community 
resources and a small number of health care providers, so 
access to care was a problem. I did not have the context to 
understand it when I was younger, but the tremendous amount 
of health inequity there is very apparent to me now. Following 
in my father’s career path as a pharmacist and subsequently 
practicing as a P.A.-pharmacist in rural communities, I had a 
personal desire to expand access to care. Rural primary care is 
hard work, but it can be very fulfilling. 
As faculty and an administrator in academic medicine, 
I still strive to expand access to care and help patients and 
families avoid the struggle to find a caring, capable provider. 
This passion fuels my work in education and research. Over 
the past several years, I have worked harder to help innovate 
how care is delivered, so we can provide it more affordably, 
more safely, and with better coordination. This pursuit also 
involves leadership to help shape health policy and modernize 
the regulatory environment so all health professionals can 
practice to the full extent of their training and experience, 
which I believe is a practical strategy to improve access, 
lower the overall cost of care, and combat the current 
geographic misdistribution of health care professionals in the 
United States. 
The talented students, dedicated staff, and passionate 
faculty within SMHS give me enormous hope for the future. 
I feel fortunate to be a part of such a distinguished university, 
and am leveraging every opportunity to build collaborations 
and benefit from the broad base of expertise in education and 
research at GW. Washington, D.C., seems like a long way from 
my beginning in rural South Carolina, but at the same time, it 
already feels a lot like home.  
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IN ACTION
hristian Hendrix had just started her first year at 
the George Washington University (GW) School 
of Medicine and Health Sciences when she was hit 
hard by the news: Within a matter of days, Philando 
Castile and Alton Sterling had been shot and killed by police 
officers. 
“A couple of students and I came to class the following 
Monday just feeling disconnected,” she recalls. “We had been 
experiencing a lot of political talk about bigotry and dividing 
the nation and doing harmful action against people just 
because they’re different from you.”
Hendrix and a few friends talked to GW faculty 
members and returned to class, sharing their 
thoughts after the lesson had wrapped. “We had 
so much support from the administration 
and from everyone in the class, through 
hugs and tears and solidarity.”
That support — and the desire to 
speak up — spurred Hendrix to do 
what so many other SMHS students 
have done before her: act.
STUDENT ACTIVISTS
GW has a long history of activism and 
advocacy — during the last several 
decades, students have supported 
HIV/AIDS research, measures for 
patient outcomes, and efforts to provide 
greater equity in health care, among other 
issues — and that is precisely why many SMHS 
students choose to attend school in the nation’s 
capital. SMHS leadership has also sought to 
continue to shape student activists.
“Every clinician needs to recognize that 
[advocacy] is part of what their scope of practice 
should be to be an excellent clinician in the 21st 
century,” says Lawrence “Bopper” Deyton, M.D. 
BY CAROLINE TRENT-GURBUZ
Christian Hendrix,  
first-year M.D. student
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’85, M.S.P.H., senior associate dean for clinical public health, 
and professor of medicine at SMHS. “We take no position in 
what we teach here on what students’ positions are or should 
be. We just want students to know how to develop their own 
viewpoints and be able to know how to advocate for their 
viewpoints when they are practicing clinicians.”
Those perspectives may be dynamic, Deyton adds, but what’s 
key is for students to embrace their passion. It’s a stance Grace 
Henry, Ed.D. ’12, director of the Office of Diversity and Inclusion 
and adjunct assistant professor of medicine at SMHS, echoes. 
“We want a social activist, but we want these students to 
recognize that the definition is crafted by themselves,” she says. 
“I truly want this generation to realize that they don’t have to 
be constrained by what they’ve seen activism to be, but that 
they have the ability to define it and be as effective as they need 
to be to make the change they want to see.”
As Henry explains, for some, activism means writing 
letters, signing petitions, and calling representatives; for 
others, it means organizing, marching, and putting a face on 
an issue. In 2014, for example, M.D. program students held a 
die-in for White Coats for Black Lives, a movement aiming 
to eliminate racial discrimination in health care, in front of 
the Foggy Bottom Metro station; in January 2017, the SMHS 
Inclusion Group posed for photos with white boards displaying 
messages of solidarity for #WhiteCoats4BlackLives.
“One thing I’m learning is that you can be involved in 
many different ways,” Hendrix says. “Involved doesn’t mean 
that you have to take on a visible, active role. Involved can be 
little things; just voicing 
awareness can be a small step 
anybody can take.”
POLITICAL ACTION
Hendrix’s own steps came 
in the form of organization. 
She joined the SMHS 
student-led Social Justice 
Interest Group, which 
focuses on inclusion, 
solidarity through helping 
those in need, and using 
its voice to advocate for 
patients.
The group also worked 
with classmates who 
added two chapters, one 
for White Coats for Black 
Lives and another for the 
American Medical Student 
Association, designed to promote medical student 
activism. “The main thing we want to do is reduce health 
“ As health practitioners, we see a lot that’s on 
the ground … we can bring the perspective 
of ‘coverage is good; coverage has helped; 
coverage has been good for patients.’  
Those are things we can see firsthand.” 
          –  Jamie Majdi,  
third-year 
M.D. student
John Marin,  
first-year M.D. student
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“ Change is only going to come when someone steps 
up, says that something is a problem, and makes 
their voice heard. I do think it’s really cool that even 
as students, we have this ability to shape what the 
future of physical therapy is going to look like, and 
that’s a really powerful tool. It’s doing ourselves an 
injustice and our future patients an injustice if we 
don’t advocate and speak up to make our care the 
highest quality it can be.” 
– Sarah Guenzburger, second-year D.P.T. student 
disparities,” Hendrix says. “We think one platform is through 
social justice.”
With that platform in mind, Hendrix joined Protect Our 
Patients, an Affordable Care Act anti-repeal campaign, and 
helped organize a D.C.-based summit in early January 2017. 
On Monday, Jan. 9, SMHS M.D. program students Jamie 
Majdi, Camilla Maybee, Mariama Evans, and Rayna Sobieski 
joined their fellow classmates and students from across the 
country at the Department of Health and Human Services, and 
together they marched on Capitol Hill, where they delivered 
the #ProtectOurPatients petition to members of Congress and 
their legislative aides.
“Because of our position as health care providers, we have a 
moral imperative to advocate for patients,” says Majdi, a third-
year M.D. student who met with aides for Sens. Dick Durbin 
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to look at health care policy in a reasonable and measured way, 
everyone would agree that more coverage is best for the people 
of the United States.”
SMHS Doctor of Physical Therapy (D.P.T.) students 
have taken a similar approach to advocacy, participating in 
the American Physical Therapy Association (APTA) Federal 
Advocacy Forum in March 2017. The forum, says Annie 
Golovcsenko, a second-year D.P.T. student, had an educational 
bent, where participants, professionals, and students alike 
heard different speakers “talk about the issues that our patients 
are having to deal with and how we can be advocates for them, 
not only in the health care field, but also on Capitol Hill to 
our legislators.” 
“It was a great time to talk to other P.T.s and P.T. students 
about ways to get involved and to advocate for our patients, and 
also figure out the most effective way to go about talking to 
our representatives,” Golovcsenko explains. “The APTA has a 
clear process to support us doing this; they were there giving us 
advice and tips to go about it.”
That approach to advocacy — speaking to representatives 
and voicing patients’ needs — is why third-year SMHS M.D. 
student Ashtin Jeney took action to ensure sure she has a “seat 
at the table.”
“It’s one thing to be vocal, it’s one thing to have an 
opinion, and it’s one thing to care about issues,” Jeney says, “but 
putting yourself at the table, with the people who are having 
the conversation to enact change, I think, is really where we 
have to [be].”
Jeney is the sole student representative on the bipartisan 
American Medical Association Political Action Committee 
(AMPAC) board. While the board works to make sure 
physicians’ voices are heard in policy and supports candidates 
who prioritize health-related issues, Jeney’s role is more 
concentrated: she raises awareness of AMPAC’s mission by 
reaching out to students. It’s an opportunity that could only 
have opened up at GW, she says.
At GW, “there are so many opportunities to get involved 
in policy, not just through our curriculum and the great things 
that we’ve gotten to do with the new [clinical public health 
theme] … but also to get involved in different organizations 
here in D.C.,” she explains.
FACE-TO-FACE WITH PATIENTS
One inspiring organization has been the Healing Clinic, an 
SMHS student-run free clinic founded in 2006 that is open to 
the community. 
“The Healing Clinic is a great way for people who want 
to get involved to, in a very direct way, help people and take 
care of patients,” says John Marin, a first-year M.D. student at 
SMHS and director of communications for the Healing Clinic. 
The clinic, which has two locations, one in Prince Georges 
County, Maryland, and another at Bread for the City in the 
District, is made up entirely of student, resident, and clinician 
volunteers.
“Being able to simultaneously give back to the community 
while working on our patient interaction and physical exam 
skills is so valuable,” says first-year physician assistant (P.A.) 
student Bailey Ernstes. “I can’t tell you how many times I’ve 
heard a classmate who’s been at Healing Clinic say ‘I’m so glad I 
went to that; it reminds me of why I want to do this.’ ”
The P.A. students, like their M.D. and D.P.T. 
counterparts, draw particular inspiration from working with 
patients in the community, and their volunteer efforts have 
extended to other groups, such as the SMHS DC Health and 
Academic Prep Program, which exposes rising high school 
seniors to health care professions. They also regularly advocate 
for their profession — P.A. students in 2015 spoke to Congress 
about P.A. research funding, diversity, and student loan 
repayment programs — and they take a class specifically on the 
role physician assistants play in health care.
“It was an eye-opening course for everyone,” says Ernstes. 
“I didn’t realize there was so much advocating that still needed 
to be done.”  
“Just being in D.C. and having so many 
faculty members in the leadership roles of 
professional organizations like the AAPA 
[American Academy of Physician Assistants] … 
I think [it gives us] a great responsibility to be 
advocates for the profession.” 
– Ellie Frye, first-year P.A. student
“The Healing Clinic definitely makes you think 
creatively. … [L]earning to navigate barriers to 
care that aren’t taught in the classroom is a 
unique opportunity that only the Healing Clinic 
can provide.” 
– Kirsten Almagro, first-year P.A. student
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THE LIGHT
BY CAROLINE TRENT-GURBUZIn all her years conducting research, Narine Sarvazyan, Ph.D., professor of pharmacology and physiology at the George Washington University School of Medicine and Health Sciences (SMHS), has had several ideas, but one 
— a cardiac imaging catheter — is the closest she’s come to 
traversing the information chasm between bench and bedside. 
“There are still many, many hoops to jump through, but 
we’re at least approaching [a clinical device],” she says. “It 
doesn’t really happen very often in basic science research. 
Usually we think, ‘Well, this might help sometime in the future 
because we are providing basic knowledge of how things work.’ 
In this case, I am cautiously optimistic, let’s put it that way.”
Seeing the Invisible
Sarvazyan’s journey began with Marco Mercader, M.D., 
director of electrophysiology research and associate professor 
of medicine at SMHS, and Matthew Kay, P.E., D.Sc., an 
associate professor of biomedical engineering at the GW 
School of Engineering and Applied Science (SEAS), when the 
three began experimenting with NADH (a reduced form of 
nicotinamide adenine dinucleotide) fluorescence imaging on 
the surface of ischemic animal hearts. “If you illuminate tissue 
with ultraviolet light, there’s a fluorescence that comes out, and 
it can be picked up and detected in the laboratory,” explains 
Mercader. “So Narine and I started experimenting with what 
would happen if you did ablation of the cardiac tissue to the 
fluorescence provided by NADH.”
Cardiac ablation, a procedure that burns or freezes 
heart tissue in an effort to correct arrhythmia, such as atrial 
fibrillation, comes with its own special set of complexities. 
Right now, Sarvazyan says, surgeons perform ablation without 
being able to see what happens to the tissue, which accounts for 
the current success rate of the procedure: Typically, 60 percent 
of patients see their arrthymia corrected, and 40 percent return 
to the hospital for an additional procedure. Out of that number, 
10 to 15 percent return one more time.
“There are different means to ablate abnormal sources 
of electrical activity, but today a surgeon does not really have 
the means to say, ‘OK, I destroyed the tissue,’ because this 
procedure is essentially done in a blind fashion,” Sarvazyan 
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Sarvazyan and her team also 
discovered that the intensity of the 
assigned color was proportional to the 
depth of the affected tissue. “Our data 
suggest that when one plots the intensity 
of the lesion component revealed by 
hyperspectral imaging, it predicts how 
deep the lesion is,” she says. “That’s 
what is known as the holy grail of atrial 
fibrillation treatment.”
In addition to the imaging fibers, 
the catheter includes an illumination 
fiber. “We need to minimize all parts 
of the catheter for it to fit inside a vein,” 
Sarvazyan explains. “So from a technical 
perspective, our main challenge is to get 
enough light to the tissue to illuminate 
it, as well as to get enough light back so 
we can actually spread it into individual 
wavelengths to do hyperspectral image 
analysis.” The team’s solution for the 
current catheter was to envelop the 
illumination fiber with a pear-shaped 
saline balloon that acts as a kind of lens, 
moving blood away from the fibers while 
lighting the way forward.
Seeking Partnership
While progress ticked along at the bench, Sarvazyan and 
Mercader, wanting to move their catheter to the translation 
phase, needed to find financial support. The first phase of the 
project, Mercader says, was funded by GW and SMHS clinical 
partner GW Medical Faculty Associates. Then, he adds, came 
the question: “How are we going to get other people interested 
in this?” 
They started by drawing attention to their work. In 
2011, the team submitted their idea to the GW Open House 
and Innovation Competition. They then filed a patent, with 
Mercader leading the way to find an investor, which he did: 
venture capital firm Allied Minds. Together, Allied Minds 
and GW formed a joint company, LuxCath, LLC, which then 
sponsored a small business, Nocturnal Product Development, 
LLC. The latter company, essential to the catheter’s 
development, is an engineering firm specializing in biomedical 
device design and manufacturing. More recently, the team 
welcomed Murray Loew, Ph.D., professor of biomedical 
engineering at SEAS, to help with additional image analysis 
and processing of algorithms.
Next, with Nocturnal Product Development as their small 
business partner, Sarvazyan’s team applied for and received a 
$200,000 National Institutes of Health (NIH) Phase I Small 
says. “There are no direct imaging tools to visualize the 
ablation process.”
That’s where Sarvayzan’s team comes into play. The 
team’s goal was to develop a new generation of cardiac imaging 
catheters that could detect changes in tissue autofluorescence 
caused by ablation. The current version of their catheter, 
designed to thread into a patient’s vein and up to the heart, has 
17,000 imaging fibers, each capable of picking up a fluorescent 
signal from the tissue and relaying it to a camera. She compares 
it to a butterfly eye, capable of using multiple receptors to 
receive light signals.
In order to see ablation lesions inside the heart, however, 
it’s not enough to have a small and flexible imaging fiber 
bundle, Sarvazyan says. Surgeons have to be able to detect 
damaged tissue beneath thick layers of collagen covering 
the inner surface of atrial tissue. “The contrast is very, very 
small,” she says. “So, to be able to reveal damaged tissue, we use 
technology called ‘hyperspectral imaging.’ ”
Hyperspectral imaging, which has long been used in 
agriculture and astronomy, is rapidly gaining popularity for 
clinical applications. With the help of a computer, Sarvazyan 
explains, it can distinguish individual pixels based on the 
small spectral differences between them, creating a color map 
showing ablated tissue and viable gaps still needing ablation.
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Business Technology Transfer (STTR) Program award in 2014. 
“Phase I allows one to have the initial funds to prove that the 
main concept works,” Sarvazyan explains.
The pace of progress slowed when it came to the larger 
STTR Phase II award. The NIH, Sarvazyan says, is keen on 
translating whatever researchers find in the lab to the real 
world, and Phase II of the grant includes elements critical 
to that goal, such as a marketing plan. “That was certainly 
uncharted territory for me,” she says, “but we got it done with 
help from a marketing firm and our business partners.” In April 
2015, she submitted the paperwork for the grant, and by July, 
the team had received a high score on the proposal, successfully 
checking off each of the criteria. 
The NIH, she says, typically awards a Phase II STTR 
grant two or three times a year. Given her past experience in 
the grant process and the top marks for her project, Sarvazyan 
thought the award was a given. At first, “obviously, everyone 
was ecstatic,” she recalls. “When you get a score like this, you 
think that you are definitely going to receive the money. But 
in the fall of 2015, the NIH changed its rules by adding yet 
another layer of selection for this specific type of grant, which 
gave us a lot of anxiety.” Sarvazyan was now caught in limbo. 
“The hardest part was that once you get this score, everyone 
you call — your chair, your students — they all assume you get 
the money,” she says. “But then for a year, we were still awaiting 
the NIH final decision, while trying to keep our team and 
spirits together. ” 
Finally, in August 2016, Sarvazyan received the news. 
“Luckily for us, the decision was in our favor.”
The two-year grant, totaling $2.27 million, is split between 
GW and Nocturnal Product Development, with Sarvazyan 
as the primary investigator. Since the award, the project has 
moved one step closer to the bedside: On Jan. 31, 2017, the team 
conducted a large animal study using the first iteration of the 
hyperspectral imaging catheter. Mercader also traveled to 
Europe to test an earlier, simpler version of the catheter to get 
feedback on its functionality. 
“We’re so very proud that the catheter made it into an 
actual catheter; it comes in a box, has a name and a serial 
number, and it was actually [used] for the first time this year,” 
Mercader says. The team went to Prague to do first-round 
testing with both U.S. and local electrophysiologists. 
For now, the team is implementing the many tasks 
outlined in Phase II and preparing for Phase III, which 
requires a matching investment from a venture capital firm or 
angel investor to qualify for NIH support. In the meantime, 
however, Sarvazyan and her team can already lay claim to a 
major milestone. They are the first at SMHS to receive an 
STTR Phase II award.
“We believe and hope that this powerful new technology 
will finally help cardiac surgeons and electrophysiologists to 
see what was once invisible,” she says.  
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O B S E R V A T I O N : 
On Autism
Opening New Doors on Autism  
and Neurodevelopmental Disorders 
BY STEVE GOLDSTEIN
Why? Because his ambitions as director of the new Autism 
and Neurodevelopmental Disorders Institute (ANDI) extend 
beyond investigation, to influence. 
“We’re interested in influencing policy decisions,” 
says Pelphrey, citing one of the three chief priorities of the 
institute, which embraces research and clinical care and will 
be housed primarily in a state-of-the-art clinical center at 
GW’s Virginia Science and Technology Campus in Ashburn. 
In addition to his role as director, Pelphrey, a boyish-looking 
43-year-old, is the inaugural Carbonell Family Professor in 
Autism and Neurodevelopmental Disorders, and professor of 
pharmacology and physiology at the GW School of Medicine 
and Health Sciences. Through ANDI, Pelphrey is creating 
a one-stop resource for families affected by autism in the 
Washington, D.C., area and beyond by connecting faculty 
members at six GW colleges with clinical partners GW 
Hospital, Children’s National Health System, and the GW 
Medical Faculty Associates. 
As part of the network, Pelphrey will be joined by Ashley 
Darcy-Mahoney, Ph.D., assistant professor of nursing at the 
GW School of Nursing and a neonatal nurse practitioner, 
who will serve as ANDI’s director of infant research. “She 
was a terrific hire that I didn’t have to do,” says Pelphrey, who 
celebrated his first anniversary at GW on April 1. 
A Firm Foundation 
ANDI received $12 million in initial funding for research. 
Pelphrey cites the recruitment efforts of GW Vice President 
for Research Leo Chalupa, Ph.D., as very persuasive, and is also 
grateful for the commitment of GW Board of Trustees Chair 
Nelson Carbonell, B.S. ’85, who gave $2.5 million to establish 
the endowed professorship Pelphrey holds. Carbonell’s son, 
Dylan, was diagnosed with autism as a 2-year-old. 
Autism is relatively common, affecting an estimated 
one in every 68 children in the United States, yet it is widely 
misunderstood. So broad are its manifestations that it is 
described as a “spectrum” disorder. Autism may be experienced 
as the gaze unmet, the outstretched hand unshaken, the 
conversation turned riddle. The disorder is a mental prison of 
sorts, in which the “inmate” has difficulty communicating and 
forming relationships with other people and in using language 
and abstract concepts. 
Close Ties and Choice Connections 
Pelphrey has two major priorities for the institute. The first, 
he explains, is building a comprehensive clinical and research 
infrastructure. If parents have concerns about their child’s 
development and they start thinking about a place to go, 
Pelphrey wants them to think of GW and ANDI. “We need to 
As one of the world’s pre-eminent autism researchers, 
Kevin Pelphrey, Ph.D., has built a reputation that 
can open the doors to virtually any medical research 
institution — and the institution would consider itself 
fortunate to have him. But Pelphrey chose The George 
Washington University (GW). 
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be able to comprehensively evaluate the patient, provide advice 
and discuss possible neurodevelopmental treatments, and have 
the research that will explain the kinds of therapies that will 
work, and ones that may not,” he says. 
The second priority is for the institute to serve as a 
national model for treatment in post-adolescence. Therapies 
for autism spectrum disorder cannot be narrowly focused 
on children from infancy to 3 years old. The adult transition, 
especially during the teenage years, is also an important 
period in brain development. “The brain is reorganizing,” says 
Pelphrey, and it presents opportunities to intervene. He adds 
that there’s “a wave of young adults with autism coming in the 
next 10 years.” 
Pelphrey has been studying brain development for 
16 years, beginning as a postdoctoral researcher at Duke 
University. Practical considerations — “it was hard to build 
academic tenure,” he notes — caused him to jump off that 
track for a while. Personal issues drove him back, intensively. 
“My daughter, Frances, was diagnosed with autism when she 
was a little over 3 years old,” he explains. “We noticed general 
developmental delays and a slowness in developing language. 
But she was very social with people and that delayed the 
diagnosis for a bit.” 
Frances, now 13, provided passion and a new focus for 
Pelphrey. “This delay in diagnosing girls compared with boys 
got me very interested in studying girls with autism,” he says. 
Why are girls such as Frances underdiagnosed? According to 
Pelphrey, boys are more susceptible to neurodevelopmental 
disorders than girls. Moreover, there’s a kind of “masking” 
related to girls in that they tend to appear more social than 
boys. “Thus you have a significant number of girls with 
problems, but they are not rising to the diagnosis level to 
get the attention they need,” he says. Pelphrey is the leader 
of an NIH-funded, $15-million multi-site project to study a 
large sample of girls with autism with a focus on genes, brain 
function, and behavior throughout childhood and adolescence. 
Darcy-Mahoney’s work addresses another under-
researched subject: the connection between autism and 
prematurity, and particularly how this is represented 
among African Americans, who have a much higher rate of 
preterm babies. “African American children with autism 
are significantly under-represented and significantly 
underdiagnosed — and probably diagnosed in a less timely 
fashion,” she says. Darcy-Mahoney, who arrived from Emory 
University in July, says the School of Nursing also has an 
Ashburn campus, “so we hope to cross-train in the area of 
neurodevelopmental pediatrics.” 
Broader Perspectives 
When Pelphrey first entered the field in 2001, autism was 
viewed very narrowly and “virtually nothing had been done 
on sex differences.” He began exploring the theory that it 
was a disorder of early brain development that changes over 
time. Now, studies have concluded that autism “is a disorder 
of mid-fetal brain development that begins in utero,” Pelphrey 
explains. Additionally, research has revealed reliable brain 
“signatures” of the disorder, which allows it to be traced 
over time. “This has gotten much more complicated than we 
ever dreamed of,” he adds, “and we’re talking about a whole 
collection of disorders.” 
ANDI will also provide cutting-edge advice on 
treatments, including behavioral interventions and 
pharmacological therapies. Pelphrey says the institute will 
explore why behavioral interventions are unsuccessful with 
some children and will employ drug interventions to increase 
responsiveness to behavioral therapies. Cognitive behavioral 
therapy will be studied as a method of treatment for older 
children and teenagers, who sometimes exhibit aggressiveness 
and social anxiety. 
Pelphrey’s familiarity with the Washington, D.C., region 
— his wife’s family owns an oyster farm in Virginia Beach, 
Virginia — helped convince him that ANDI could have a 
wider impact. “We will be able to get attention through direct 
contact with policy-makers,” says Pelphrey, who is on the 
federal Interagency Autism Coordinating Committee. “That 
prospect is very exciting.”   
“On Autism” is the first installment of a new online, long-form nonfiction series, 
OBSERVATIONS, covering several of the George Washington University School 
of Medicine and Health Sciences areas of academic excellence. Look for the next 
installment of “On Autism” at observations.smhs.gwu.edu.
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A t the  George Washington University (GW) Transplant Institute in January 2017, Jose Reyes and Andrew Lewis stood in the waiting room. The two — each of whom had received a kidney from 
an anonymous donor in mid-December 2016 — watched as the 
door to the exam rooms opened.
“Meet your donor!” said J. Keith Melancon, M.D., chief 
of the Division of Transplant Surgery, director of the  GW 
Transplant Institute at GW Hospital, medical director of the 
GW Ron and Joy Paul Kidney Center, and professor of surgery 
at the GW School of Medicine and Health Sciences (SMHS).
Lewis stepped back, visibly moved and struggling to form 
words when Jacob Lambdin, a third-year medical student at 
SMHS, approached. 
“I’m speechless, but at the same time, I have so much I 
want to say,” Lewis said. “I am so grateful.”
Lambdin, who plans to pursue surgery, explained his 
SMHS donors provide “gift of life” to 
kidney patients in December 2016
decision to give his kidney to Lewis simply: “Whenever people 
ask why I decided to donate, I tell them ‘It’s a good thing to do, 
why not?’ ”
Reyes, meanwhile, didn’t believe who his donor was; 
he’d been convinced it was a man. Instead, Sarah Miknis, 
photographer and production assistant with Biomedical 
Communications at SMHS, walked out. 
“You?” Reyes asked, as he enveloped Miknis in a hug.
Like Lambdin, Miknis felt compelled to donate. She’d 
been on a bone marrow list for years, but never got the call for 
a match. In the meantime, as an SMHS photographer, Miknis 
had covered many kidney screenings and health events, and 
decided that giving her spare organ to someone in need was the 
right thing to do.
“If I’m healthy and I can [help] somebody, I want to do it,” 
she said. “I have two kidneys, but I only need one.” 
Donating, she added, wasn’t as hard a process as she’d 
anticipated — she had multiple screenings and was given ample 
time to consider her decision — and by winter, she was ready. 
Both she and Lambdin donated within a day of each other, 
effectively providing Lewis and Reyes with what Melancon 
termed “the gift of life.”
“With everything that’s going on in the world, the 
one thing I get asked all of the time is ‘why?’ ” Melancon 
continued. “All I can say is, ‘I don’t know, but it gives me faith 
in humanity.’ [When you donate,] you’re not giving a kidney. 





 straight line might be the shortest route between two points, but it’s not always the most desirable course. For J. Carl Craft, M.D. ’72, a more direct path might have led him far afield from his ultimate 
career, and the world of pharmaceutical research would have 
been far poorer as a result.
In high school, Craft was groomed for Stanford 
University’s nuclear physics program; the father of a close 
childhood friend was a researcher building the university’s 
linear accelerator, and together, Craft and his friend were 
regular visitors to campus, eagerly exploring the accelerator 
and the computer equipment. As high school graduation 
approached, however, Craft determined that nuclear physics 
was not his path. 
His next twist came during medical school. Initially, 
Craft considered studying psychiatry, but soon decided you 
“had to be crazy to do psychiatry,” though, he adds, “being 
a nuclear physicist was even crazier.” By the time he left 
for George Washington University’s (GW) Foggy Bottom 
campus, he had his sights set on pediatrics — but his path had 
one more kink in store. 
The summer before his third year of medical school, Craft 
took a summer job with Hazleton Laboratories in Virginia, 
working on a project gathering data on Cromolyn sodium, an 
asthma medication. “I collected and evaluated the data, then 
wrote the package insert [the description and classification, 
regulatory specifications, and drug interaction materials] for 
the drug,” he says. The total new drug application filing was six 
copies of 92 volumes.
That experience foreshadowed Craft’s future in 
pharmaceuticals, but years would pass before he found himself 
working in the industry.
Craft graduated from GW a married man in 1972, and 
he and his wife, Susan, moved to Wisconsin for his pediatrics 
residency at Milwaukee Children’s Hospital. It was the Vietnam 
Era when he completed residency, he recalls, and those who 
guaranteed two years of military service could select the branch 
they would join. Craft joined the Navy. “That allowed me to 
finish my training,” he explains. “I entered as a pediatrician 
[serving in Guam as lieutenant 
commander and chief of pediatrics at the 
U.S. Naval Regional Medical Center], 
which was lucky since the war ended 
and 100,000 women and children were 
temporarily housed on Guam before 
being moved to the mainland.”
Following military service, Craft 
started a pediatric infectious disease 
fellowship at the University of Texas 
Southwestern in Dallas under the 
guidance of George McCracken, M.D., 
and John Nelson, M.D., founders of The 
Pediatric Infectious Diseases Journal. 
He later joinedthe faculty at Tulane 
University in New Orleans, where he 
treated patients with infectious diseases, 
taught students, residents, and fellows, 
and was an investigator in clinical trials 
for pediatric antimicrobial drugs. 
Despite his steady progression in 
medicine, Craft felt himself drawn to 
clinical drug research — specifically 
to Abbott Laboratories, where he 
developed the antibiotic clarithromycin, the first billion-dollar 
drug. When the pharmaceutical giant decided to move out of 
anti-infective drug development, however, Craft retired, but 
kept an eye open for the next turn of his career path.
That turn came up quickly in the form of Medicine for 
Malaria Venture (MMV), a new, nonprofit foundation funded 
by The Bill and Melinda Gates Foundation (BMGF) and 
others, designed to work on malaria drugs. At MMV, Craft, 
who served as chief scientific officer, developed the largest anti-
malaria drug portfolio to date. MMV has continued to work 
to eliminate malaria with new medications, created with the 
stipulation that they cost no more than $1 per treatment. 
Both during and after his tenure at MMV, Craft served as 
a scientific adviser to Drugs for Neglected Disease Initiative 
in Geneva, a nonprofit drug research and development 
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organization that works on new treatments for neglected 
diseases, such as leishmaniasis, Chagas disease, and parasitic 
infections. He also served as a scientific adviser to an 
ANACOR Pharmaceutical and BMGF project to develop new 
drugs for tuberculosis and macrofilarial diseases. Rounding out 
his role as a scientific adviser, Craft, who maintained the role of 
chief medical officer as well, helped start a new drug company, 
CEMPRA Pharmaceutical, which is developing two anti-
infective agents for serious infections.
More recently, Craft launched Aquarius Biotechnologies 
Inc. The company, he says, has developed new delivery 
technology for large-molecule drugs that cannot be 
absorbed from the gastrointestinal (GI) tract. When given 
intravenously amphotericin B can decrease nephrotoxicity. 
Only through nanotechnology, or cochleates, can molecules 
like amphotericin B be taken orally. The cochleates, he 
explains, are absorbed across the GI tract, actively taken up 
by macrophages within the blood stream, and delivered to the 
site of infection through the patient’s lymphatics. As a result, 
high levels of the drug do not appear in the blood stream, 
which could decrease kidney damage.
This unique drug delivery technology, he adds, can 
formulate and stabilize a variety of molecules, including 
pharmaceutical drugs; insulin and vaccines; peptides; DNA 
plasmids, or gene therapy; and siRNAs.
Craft’s career may have drawn him away from his 
high school plan of studying nuclear science, but the path 
he followed led to an illustrious career of discoveries in an 
innovative medical field.   
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On an evening last summer, Francis L. Delmonico, M.D. ’71, and his wife, Janice, attended a fundraising dinner at the tony Beacon Hill residence of Martin Walsh, the mayor of 
Boston. With Mayor Walsh and the Delmonicos that night 
was Monsignor Marcelo Sánchez Sorondo, chancellor of the 
Pontifical Academy of Sciences. Seated at their table was 
Jack Connors, CEO of the Board of Trustees for the Partners 
Complex of the Massachusetts General and Brigham and 
Women’s Hospitals. Looking out at the tables surrounding 
them, the Delmonicos saw a room packed to capacity with 
Boston’s social elite.
“We’re looking at each other, thinking ‘what are we doing 
at this table?’ ” chuckles the genial, self-effacing surgeon. Of 
course, the couple knew exactly why they were there — to raise 
money in support of the Pontifical Academy of Sciences and its 
mission to fight the global trade in human organs — but the real 
question was how did they get there. 
Less than a year earlier, on Feb. 15, 2016, Pope Francis 
named Delmonico to the Pontifical Academy of Sciences, 
a centuries-old scientific community founded to “honor 
pure science wherever it may be found, ensure its freedom, 
and encourage research for the progress of science.” The 
lifetime appointment puts Delmonico among 80 of the 
world’s most eminent scientists and academicians, those 
acknowledged as much for their “moral personality” as their 
intellectual accomplishments. 
“I was not accepted [to medical school at George 
Washington University] the first time I tried,” recalls 
Delmonico, marveling at the distance his medical career has 
covered. “The dean of admissions at that time, Paul Calabrisi, 
Ph.D., told me ‘you’re not going to get in this year. You have to go 
back and retake the medical admission test again. If you improve 
your score, and then you come back to me, you’ll do well here.’ ”
The reassurance, Delmonico says, changed his life. “It 
gave me the confidence to come back — the notion that if I 
Championing an End to  
Organ Trafficking 
Francis L. Delmonico, M.D. ’71
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worked hard, I’d have a chance. I loved GW. It was a great 
place to go to school.”
Since that early setback, Delmonico has built 
a breathtaking resume that features, among other 
accomplishments: professor of surgery and Emeritus Director 
of Renal Transplantation at Harvard Medical School and 
Massachusetts General Hospital; recipient of the National 
Kidney Foundation’s David M. Hume Lifetime Achievement 
Award; adviser to the World Health Organization in matters 
of organ donation and transplantation since 2006; and 
current chief medical officer of New England Donor Services, 
which oversees all deceased organ and tissue donation for 
New England. 
With his appointment to the Pontifical Academy — which 
features among its membership scores of Nobel laureates, such 
as Werner Arber, Ph.D., president of the Pontifical Academy; 
David Baltimore, Ph.D.; and Ada E. Yonath, Ph.D., as well as 
noted physicist Stephen Hawking, Ph.D. — Delmonico has 
ascended to some rarified heights for a middle-class kid from 
Brooklyn, N.Y. 
Selection to the academy, unexpected as it may have been 
to Delmonico, makes perfect sense on closer inspection. By all 
accounts, the agenda laid out by Pope Francis is progressive; 
topics such as refugees, climate change, immigration, and the 
marginalized are regularly featured in his writings and addresses. 
Within discussion of the marginalized, explains Delmonico, you 
find human slavery, and that is where you find organ trafficking. 
The social media-savvy pontiff made his feelings on the subject 
unequivocal in an August 2016 tweet: “New forms of slavery such 
as human and organ trafficking, forced labor, and prostitution 
are true crimes against humanity.”
Delmonico, who was in Vatican City leading a two-day 
summit on organ trafficking and transplant tourism in 
February 2017, is well-versed on the subject and its associated 
crimes of exploitation, coercion, and kidnapping. The market 
for human organs is big, he says, estimating that organ sales are 
involved in as many as 13,000 transplants each year, adding, 
“we are trying to report instances of organ trafficking to the 
appropriate authorities.”
In 2011, Global Financial Integrity, a nonprofit research 
and advisory organization that analyzes international financial 
systems and illicit revenue, reported that the illegal organ trade 
had grown to be a $1.2 billion industry. The World Health 
Organization also reports that all-inclusive kidney transplant 
packages can be had, for those who can afford them, for prices 
ranging from $70,000 to $160,000. 
In the United States, a vast health care network has 
evolved to facilitate transplants through both deceased and 
living donations. Health insurance helps meet the high costs 
of surgery and a lifetime of anti-rejection medication, enabling 
the middle class and even the poor to receive lifesaving organ 
transplants. That system, however, is not universal. 
Wherever the rule of law has broken down, Delmonico 
says, you’ll have people ready to prey upon the desperate, and 
there you’ll find organ trafficking. In these destabilized regions 
of the world, such as Afghanistan, “people are taken from 
their villages, thinking they’re going to have a job when they 
reach their destination. [Instead] they’re taken to some place, 
confined,” he says. “They’re held, kidnapped. There is no job. 
And they’re told, ‘You’ll sell your kidney or we’ll harm you by 
turning you over to the Taliban.’ That’s human slavery.”
At the end of the two-day summit, participants issued 
a statement, concluding that “organ trafficking and human 
trafficking for the purpose of organ removal are true crimes 
against humanity [that] need to be recognized as such by all 
religious, political and social leaders, and by national and 
international legislation … we, the undersigned participants 
of the Pontifical Academy of Sciences Summit on Organ 
Trafficking and Transplant Tourism, resolve to combat these 
crimes against humanity through comprehensive efforts that 
involve all stakeholders around the world.”
What would the best outcome for the summit look like? 
Ideally, Delmonico says, engaging governments, using the 
stature of the Pontifical Academy, to take action on organ 
trafficking. Realistically, he understands the situation may 
not change unless the academy has the support of a larger 
community of media, governments, and medical professionals.
“The best way to put it,” he says, is “the summit is leading 
to action items, an action agenda to specific locations to 
make change.”  
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frican trypanosomes are masters of disguise. 
Delivered through bites from the tsetse fly, once 
inside a host these parasites quickly disguise their 
appearance in a process called antigenic variation, all 
to avoid detection — and no parasite does it better. 
But how do organisms like trypanosomes, in their effort to 
colonize an inhospitable environment, regulate their genes and 
fool an animal that doesn’t want them there? That is the crux of 
Galadriel Hovel-Miner’s research.
Hovel-Miner, Ph.D., assistant professor of microbiology, 
immunology, and tropical medicine, opened her lab at the 
George Washington University (GW) School of Medicine 
and Health Sciences (SMHS) in December 2015. Her goal was 
to uncover the genetics behind a parasite’s ability to infect its 
host, and attribute those genes to their function. Doing so 
could expose gaps in the parasite’s defenses, leading to future 
targeted therapeutics. When it comes to trypanosomes, Hovel-
Miner notes, that goal is a little daunting; so far, more than 60 
percent of the genome remains a mystery.
Trypanosomes thrive in sub-Saharan Africa and spread 
African sleeping sickness. Ultimately, the trypanosomes’ 
genetic shroud enables them to slip across the blood-brain 
barrier undetected, where they enter the central nervous 
system. In the late stages of the disease, infected humans and 
other animals lose their sleep pattern; they sleep all day and are 
awake all night. The sleeping sickness itself, explains Hovel-
Miner, is the end stage of the disease, caused by brain damage. 
The illness not only affects thousands of people living in 
sub-Saharan Africa, but also lays waste to livestock, financially 
devastating already poverty-stricken regions.
In addition to the human suffering the parasites create, 
Hovel-Miner says there are two other reasons her lab is 
interested in trypanosomes: They are the textbook parasite 
for antigenic variation, and their method of disguise is unique, 
accomplished by shuffling genes around in the genome.
That gene shuffling is perhaps one of the most intriguing 
aspects of her work, says Hovel-Miner. Trypanosomes, to 
perform antigenic variation, have only one gene expressed, 
or turned on, at a time. Unlike other 
pathogens that may have just a few 
antigenic genes at their disposal, 
trypanosomes have more than 2,000 
cloaks with which to shroud their 
identity.  
“How do you go from one [gene] to 
one of the other 2,000? That’s really the 
question,” Hovel-Miner says.
Normally, in a mammalian genome, 
moving the genes around would be very 
dangerous, she adds. “It’s something you 
pretty much want to do only when you’re 
an egg and a sperm coming together 
to make a new person or animal, a 
genetically unique one. A lot of times 
moving things around in the genome 
… can result in genetic disorders and 
cancers. These are the kinds of actions 
that cause genetic damage, which can 
result in disease,” she explains.
Understanding how trypanosomes 
efficiently move a silent gene from 
one position in the genome to become 
active in another position without 
incurring extra damage would open 
doors to an even better grasp not only of 
trypanosomes’ use of antigenic variation, 
but also of the genetics associated with 
human disease overall, Hovel-Miner 
says.
The lab is also investigating the drug 
resistance of trypanosomes. Knowing 
which genes lead to drug resistance could 
help researchers identify new pathways 
associated with that resistance. 
Although currently many stages 
away from the long-term goal of having a 
BY KATHERINE DVORAK
30 MEDICINE + HEALTH   |   SPRING 2017
testable drug, Hovel-Miner hopes to find a better treatment for 
the disease that would inhibit the growth of the trypanosome.
“There are drugs, but there are only a limited number 
of them, and while they’re fairly effective, they’re also highly 
toxic. There aren’t very many of them, so drug resistance is a 
threat, and any resistance could be a real problem,” she says.
To learn more about the parasites’ genes, Hovel-Miner 
employs a genetic tool known as a “whole genome gain-of-
function library.” 
“This is a library of every gene in the trypanosome genome 
that we can turn on when we want to. So we put all the genes 
that we have under our control into a population of cells, we 
treat the cells with a condition, and then we see what genes are 
present post-treatment,” she explains. 
Lab members are also modifying genes in the organism, 
as well as looking at how the genes of the trypanosome move 
through the genome. 
“We know that [gene shuffling] begins with a DNA break, 
so we can look at how DNA breaks form and, following the 
formation of a DNA break, [examine] how things shuffle,” 
Hovel-Miner adds. “It now looks like some of this is associated 
with cell division and cell division defects. We’re starting to 
[look closely at] how the cells divide, because our data suggest 
that it’s connected.”  
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obbie Russell walked onto the soccer pitch to the 
thunderous sound of 80,000 voices singing: “Die 
meister [the masterful], die besten [the best], les 
grandes equipes [the great teams], the champions.”
That was 13 years ago, and Russell was a right back playing 
for Norwegian professional soccer club Rosenborg BK. It was 
one of his first matches in the Champions League, an elite 
European soccer tournament. 
“To this day, hearing that song gives me goosebumps,” he says.
Now a third-year M.D. student at the George Washington 
University (GW) School of Medicine and Health Sciences, 
Russell has come a long way from the soccer field. But every 
step he’s taken — from playing for clubs in Norway, Denmark, 
Salt Lake City, and Washington, D.C. — has led him to his 
dream of practicing medicine. 
Russell first came to GW looking to study orthopedic 
surgery; it’s what impressed him from watching doctors tend to 
his teammates. Once at GW, his interests shifted to emergency 
medicine, partly because of the pace and the day-to-day 
challenges. “I love the fact that coming into work, I don’t know 
what I’m going to see. It’s very exciting; it’s very scary,” he says.
So far Russell is making the most of his time at GW. He serves 
as vice president of the Student National Medical Association, as 
co-president of the GW Emergency Medicine Interest Group, and 
as a member of the D.C. Department of Health’s Medical Reserve 
Corps, managed by the GW Medical Faculty Associates, a medical 
response and disaster team. 
Russell discovered his aptitude for soccer during high 
school. His mother worked three jobs to help support the 
family, but affording college seemed out of reach. Russell’s 
prowess as a player paid off, however, and Duke University 
offered him an athletic scholarship. 
Despite his success as an athlete, Russell says he was always 
drawn to science. 
“I started off college as pre-med, but then I walked into my first 
calculus course and bombed it. So I thought, ‘I can’t threaten my 
GPA, I’ll just do the general athlete program and go from there.’ ”
The “from there” turned into a 14-year professional soccer 
career that Russell greatly cherishes. 
When Russell was traded to D.C. United in 2011, 
“everything started to align.” He was finally living in the same 
city as his wife, Tiana, who worked in D.C. while he played for 
Real Salt Lake. After retiring from soccer, Russell completed a 
post-baccalaureate premedical program, and was accepted as an 
M.D. student at GW.
Russell now puts the focus and drive he showed on game 
day into his work at GW, and spends his free time with Tiana 
and their two sons, Leo and Lucas. 
“Everything that’s ever happened to me, good or bad, has 
taught me something. And if I don’t apply it now, I’m doing 
those experiences a disservice,” he says. “I hope to bring all of 
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A
s a child growing up in a small village in western 
Paraguay called Santa Rosa, Cheralyn Hendrix, M.D., 
recalls standing by her father’s side as he sewed up a 
gash from an ax wound on the palm of a 12-year-old 
boy’s hand, and spending mornings and afternoons with her 
mother as she provided aid to the community of 150 people. 
“That’s really how my interest in medicine began, being 
this right-hand person in this tiny little clinic that my mom 
started,” says Hendrix, a surgery resident at the George 
Washington University (GW) School of Medicine and Health 
Sciences (SMHS). 
Hendrix’s parents worked as missionaries in Paraguay 
for 25 years. Her mother started a vaccination program in the 
village and educated its members about medication adherence; 
her father helped with wound care and suturing. 
Her parents’ dedication to their patients and the 
community is at the core of what drives Hendrix in her work at 
GW. “They’re so passionate about it, and I want my life to have 
that kind of passion,” she explains.
Hendrix lived in Paraguay until she was 18, at which point 





medicine. She has moved all over the country with her husband, 
who serves in the U.S. Air Force, while raising four children, 
the youngest of whom is 9. 
“They’re really why I can do what I do,” she says of her 
family. “I feel like I have an added measure of stability, because 
I have this incredible support structure at home. They’re really 
proud of me, and I can’t even tell you what that does for me [in 
terms of] spurring me on.”
Hendrix earned her medical degree from the University of 
Arizona at Tucson, and now, in her second year of residency at 
GW, is pursuing trauma surgery. She made that career decision 
in part because of the hands-on time she spent helping her 
parents care for their patients in Paraguay.
“I never felt as invigorated or as inspired as I did when I 
was working on surgical rotation. That was the one thing I 
found in medical school, that it didn’t matter how many hours I 
worked, I was thrilled to be working with my hands,” she says. 
“I’d rather be tired and fascinated than working fewer hours 
and feeling like I’m not doing what I most enjoy. I love never 
knowing what’s coming through the door.”  
 GWMEDICINEHEALTH.COM 33
ith the support of grants from the National 
Institutes of Health (NIH), Pedro A. José, M.D., 
Ph.D., professor of medicine in the Division of 
Renal Diseases and Hypertension and professor 
of pharmacology and physiology at the George Washington 
University (GW) School of Medicine and Health Sciences, is 
exploring how the body disposes of salt. Salt sensitivity is an 
underdiagnosed condition of hypertension, and insight into the 
process may lead to more personalized treatments for patients.
Sodium channels in the stomach sense salt levels in the 
food, José says, and those cells secrete the hormone gastrin, 
to alert the kidneys that they need to make more dopamine; 
gastrin and dopamine team up to rid the body of the excess salt. 
For some people, taking in too much salt will cause blood 
pressure (BP) to rise, but about 15 percent of people see higher 
BP if they take in too little salt, José says. The trouble, he adds, 
is that there’s no way to know who falls under which category.
Discerning how the stomach senses salt levels, and 
the channel of communication through which gastrin tells 
the kidneys to make more dopamine, may lead to a better 
understanding of salt sensitivity, says José.
To investigate how the communication occurs, researchers 
put catheters into mice blood vessels that go into the stomach 
and the duodenum. Next, they added short interfering RNA 
(siRNA) to genetically disrupt the gene, he explains. “So, if 
you put in the siRNA … [and] direct that against the sodium 
channel, you’ll only be disrupting the sodium channel in the 
stomach and duodenum.”
By limiting the disruptions just to sodium channels in the 
stomach, the technique prevents the body from making excess 
hormones in other areas that can be harmful, José adds.
The current NIH grants through which José is conducting 
his research include “Renal Dopamine-1 Receptor Defect in 
Hypertension,” a recently renewed grant for a total of more 
than $1.7 million, as well as a grant totaling more than $3.7 
million awarded to GW via the University of Virginia, for 
which José is a subcontractor, “Dopamine and Angiotensin 
Receptor Interactions in Genetic Hypertension.”
BY KATHERINE DVORAK
In addition to his research at GW, José is wrapping up 
a yearlong stint as the chair of NIH’s Hypertension and 
Microcirculation Study Section. The study sections review and 
approve grants admitted for funding. 
“It’s important that one [reviews the grants] to ensure the 
review process is fair, and that the review process really comes 
up with the best proposals to be funded by our government,” 
he says.
It’s not his first rodeo with NIH study groups. José 
previously chaired the same study section, which was 
previously called the Cardiovascular and Renal Study Section 
B, from 1996 to 1998.  
34 MEDICINE + HEALTH   |   SPRING 2017
A New Disorder
M. Chiara Manzini’s curiosity was piqued 
when she met a set of new patients.
“The patients were very short, and 
they had skeletal deficits,” explains 
Manzini, Ph.D., an assistant professor 
at the George Washington University 
(GW) Institute for Neuroscience and 
the Department of Pharmacology 
and Physiology at the GW School of 
Medicine and Health Sciences. 
In the severe forms of congenital 
muscular dystrophy she studies, 
patients typically present with progres-
sive muscle weakness as well as 
intellectual disability and vision issues 
such as cataracts. The additional 
characteristics her patients displayed, 
however — short stature and unique 
skeletal features — were highly unusual.
Manzini collaborated with scien-
tists from around the globe, and 
they discovered that the removal of a 
specific gene, INPP5K, resulted in the 
muscle disruption, lens disruption, and 
smaller brain that she had observed. 
In other words, Manzini and her fellow 
researchers had discovered a new type 
of congenital muscular dystrophy.
Leading Education at 
GW Cancer Center
Robert Siegel, M.D. ’77, has been selected 
to serve as the George Washington 
University (GW) Cancer Center’s asso-
ciate center director for education and 
training. Siegel joined the GW School 
of Medicine and Health Sciences in 
1982 as a professor of medicine.
His research interests focus on 
refining therapies for breast and head/
neck cancers. He has supervised the 
medical school’s second-year program 
in hematology since the fall of 1982, 
and is the director of the GW Board 
Review Course, the largest program of 
its kind focusing on hematology and 
oncology in the country.  
Crusading for Clinical Trials
Sitting in his office on the eighth floor 
of the Science and Engineering Hall, 
Mitchell Smith, M.D., Ph.D., associate 
center director for clinical investi-
gations at the George Washington 
University (GW) Cancer Center, lays 
out his vision for a center that pioneers 
new treatments, rapidly delivers them 
to patients, and engages with the 
community it serves.
“It’s always been the goal to take 
good care of patients, but now we want 
to be on the cutting edge in terms of 
research and providing access to new 
drugs for patients,” he says.
In his role, Smith oversees all 
cancer clinical trials. He sees the GW 
Cancer Center becoming a hive of 
activity, opening new trials at a fast clip, 
while developing a strong focus on 
in-house science. 
“We have to streamline all the 
paper and the regulations, make sure 
we can be nimble in terms of someone 
approaching us with an interesting 
study we want to do. We want to open 
those trials quickly, and we have to 
demonstrate that we can [attract] 
patients to them,” he says. 
Smith also works to enhance trust 
in the community to grow participation 
in the trials the center runs. It’s the GW 
Cancer Center’s job to reach out to 
people living in underserved commu-
nities and educate those residents, 
he adds.  
The group has since published two 
papers and is working to better under-
stand how the INPP5K gene functions 
in the muscle and the brain.
“The gene is very interesting, so 
we’re definitely going to keep pursuing 
it,” Manzini says. “Hopefully, it’s going 
to be interesting to other people. From 
a science standpoint, it’s a different 
mechanism from what had been previ-
ously looked at in these disorders. It may 




Give Me Some Skin
An international survey on sun 
exposure behaviors and skin cancer 
detection found there are many imper-
fections and geographic inequalities in 
prevention of skin cancer. 
Information from the study, 
published in the Journal of the 
European Academy of Dermatology 
& Venereology by researchers 
from La Roche-Posay and the 
George Washington University 
(GW) Department of Dermatology, 
could help inform future awareness 
campaigns developed to address 
the need to reduce the incidence of 
skin cancer. 
With nearly 20,000 participants 
around the world, it was one of the 
largest international studies of its 
kind on consumer sun protection and 
behaviors. Survey results indicated 
The Connection between 
HIV and Cancer
With a $2.2 million National Cancer 
Institute grant, Douglas Nixon, M.D., 
Ph.D., chair of the Department of 
Microbiology, Immunology, and 
Tropical Medicine and Walter G. Ross 
Professor of Basic Science Research 
at the George Washington University 
(GW) School of Medicine and Health 
Sciences (SMHS), alongside GW 
collaborators, is examining how human 
endogenous retroviruses (HERVs) 
impact certain types of cancers. 
HERVs are ancestral remnants of 
past viruses that, passing from mother 
to child, have been integrated into 
DNA. Nixon’s research team, which has 
published studies on the effect of HIV 
infection on HERVs, has found there 
may also be a link between HIV and 
cancer. 
“It appears that breast and 
prostate cancer are found less 
frequently in HIV-infected people than 
in the general population,” Nixon says. 
Nixon and his team hypothesized 
that HERVs stimulate an immune 
response, which surveils prostate 
and breast cancer cells that could be 
expressing the same HERVs. To test 
this theory, Nixon, with Ph.D. rotation 
student Matthew Bendall and Keith 
Crandall, Ph.D., director of the GW 
Computational Biology Institute at 
the Milken Institute School of Public 
Health at GW, developed “Telescope,” 
a computational pathway program, to 
determine which HERVs are expressed 
in prostate, breast, and colon cancers, 
in patients with and without HIV. 
“This is really a brand new tool, 
which we think will be incredibly 
valuable to look for expression of these 
endogenous retroviruses in a number 
of different disease categories, 
including in cancer,” Nixon says.  
that 88 percent of respondents were 
aware of the risks of developing skin 
cancer when exposed to the sun 
without protection. However, four in 
10 respondents said they don’t think 
to protect themselves from the sun 
outside vacation.
“This is a global wake-up call,” says 
Adam Friedman, M.D., senior author 
for the study and associate professor 
of dermatology at the GW School of 
Medicine and Health Sciences. “There 
are still a lot of gaps in people not only 
actively monitoring for cancer, but 
preventing it.”
According to the data, using 
sunscreen and wearing sunglasses 
were the most frequent preventive 
measures. Education level, as well as 
gender, influenced the degree of sun 
protection: A higher level of educa-
tion corresponded to a higher level of 
sun protection.  
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Patricia Berg Selected as 
2016 AAAS Fellow 
The American Association for the 
Advancement of Science (AAAS) 
named Patricia Berg, Ph.D., professor 
of biochemistry and molecular 
medicine at the George Washington 
University School of Medicine and 
Health Sciences, a fellow of the AAAS. 
Berg was selected for her “impor-
tant contributions to cancer research 
with the discovery of BP1 protein, acti-
vated in 80 percent of breast cancers 
and 70 percent of prostate cancers,” 
according to the AAAS.
Berg also discovered that the pres-
ence of BP1 protein increases as breast 
cancer progresses from normal tissue 
to aggressive breast cancer. BP1 is 
associated with increased cell growth, 
resistance to drugs, and metastasis. 
Moreover, BP1 protein can control 
other genes, including several onco-
genes known to cause breast cancer. 
Her work has had a dramatic effect on 
cancer research.  
Streamlining a Solution
In March 2017, Raja Mazumder, Ph.D., 
associate professor of biochemistry 
and molecular medicine at the George 
Washington University School of 
Medicine and Health Sciences, and 
his team, including research asso-
ciate Charles Hadley King, hosted a 
public workshop for more than 300 
participants at the National Institutes 
of Health to get feedback on “biocom-
pute objects.”
Between the Beats
A new technology, bioelectric impedance cardiography 
(ZCG), which assesses blood flow in the chest to make 
inferences about heart function, may lead to a new way to 
identify heart problems. Now, with the help of the Health 
Sciences Emerging Scholars grant, George Washington 
University’s Josh Woolstenhulme, Ph.D., D.P.T., looks to 
prove the effectiveness of that technology.
Woolstenhulme, an assistant professor in the 
Department of Physical Therapy and Health Care Sciences, 
explains that ZCG is different from traditional tools used 
to assess heart function because it relies on the electrical 
impedance of blood in the chest to determine how much 
blood is pumped out of the heart during each beat.
The primary focus of Woolstenhulme’s project is to 
validate the use of ZCG to assess diastolic function — the 
part of the heart cycle when the heart is between beats and 
filling with blood — while a patient is at rest, and while he or 
she is exercising. Validating the technology for this purpose 
might enable clinicians to better identify the presence of 
diastolic dysfunction.  
Biocompute objects, or records 
with various data, such as valida-
tion kits, the associated metadata of 
executable programs, and software 
arguments and version information, 
could allow for consistent and accurate 
computation evaluations for studies 
submitted to the FDA. To jump-start 
the development process, however, 
Mazumder’s team looked to the scien-
tific community for input.
“The goal of the workshop was 
to develop a community and engage 
it in getting together to set these 
standards. We did a good job accom-
plishing that,” King says, adding that 
the “biggest win” from the workshop 
was outside agencies agreeing to 
develop biocompute objects on their 
platforms.
The team is already planning 
another workshop for 2018. “[The 
March workshop] was well received, 
and we’re [continuing] to work with the 
community because things like this 
require lots of collaboration and input,” 




Juliet Lee, M.D., assistant professor 
of surgery at the George Washington 
University School of Medicine and 
Health Sciences, recently joined the 
ranks of the International Association of 
Health Care Professionals (IAHCP) with 
her upcoming inclusion in The Leading 
Physicians of the World. The IAHCP, a 
networking organization, is composed 
of more than 30 different medical 
specialties and provides members with 
a platform for connecting with others 
in the industry, including patients, 
experts, and colleagues.  
Election
The Physician Assistant Education 
Association (PAEA) now boasts lead-
ership from two George Washington 
University School of Medicine and 
Health Sciences faculty members: Lisa 
Mustone Alexander, Ed.D. ’03, P.A.-C ., 
M.P.H. ’89, professor of physician assis-
tant studies, was elected president, and 
Howard Straker, P.A.-C., M.P.H., assistant 
professor of physician assistant studies, 
will serve a second term as secretary.  
Mary Ottolini Receives 
Lifetime Medical Education 
Achievement Award
Mary Ottolini, M.D., M.P.H., vice chair 
of medical education at Children’s 
National Health System and professor 
of pediatrics at the George Washington 
University School of Medicine and 
Health Sciences, received a Lifetime 
Medical Education Achievement Award 
from the Council on Medical Student 
Education in Pediatrics (COMSEP).
COMSEP was established in 1992 
with the support of the Association of 
Medical School Pediatric Department 
Chairs and became an independent 
organization in 2015. It promotes 
the importance of pediatric medical 
student education.  
Leadership and Service
Benjamin Blatt, M.D., professor of 
medicine at the George Washington 
University (GW) School of Medicine 
and Health Sciences, received the 2017 
Distinguished Service and Leadership 
Award presented by the Association of 
American Medical Colleges Northeast 
Group on Educational Affairs (NEGEA).
The Distinguished Service and 
Leadership Award is presented to 
individuals selected by the steering 
committee who offer a significant 
contribution to the NEGEA initiatives 
through the years. “There are other 
people who have made great contri-
butions,” Blatt said of the honor. “I’m 
lucky to be the one who was selected.” 
His contributions include serving in 
NEGEA leadership positions, founding 
several initiatives, delivering numerous 
presentations, and coordinating two 
annual meetings at GW.
Blatt received the award during 
the 2017 NEGEA Education Meeting at 
the University of Rochester School of 
Medicine and Dentistry, May 6.  
Setting the Standard for 
Safe Practices
John M. Young, D.P.S., assistant 
professor of clinical research and 
leadership at the George Washington 
University School of Medicine 
and Health Sciences, was recently 
appointed to the Federation of State 
Boards of Physical Therapy (FSBPT) 
board of directors.
For more than 25 years, the FSBPT 
has paved the way for public protection 
by providing service and leadership 
that promote safe physical therapy 
practices. The board of directors 
for the FSBPT includes members of 
member boards, of which there are 53, 
administrators of member boards, and 
public members. Young was elected 
for a one-year appointment with the 
option of renewal up to 10 years.  
Raising the Profile of 
Team-Based Care
Karen Wright, Ph.D., P.A.-C., interim 
chair and program director of the 
Department of Physician Assistant (P.A.) 
Studies at the George Washington 
University School of Medicine and 
Health Sciences, was recently selected 
by the board of the American Academy 
of Physician Assistants (AAPA) to serve 
a two-year term as the medical liaison 
between the AAPA and the National 
Association of Medical Minority 
Educators, Inc. (NAMME).
With a mission of transforming 
health care through patient-centered, 
team-based medical practice, said 
Senior Director for Professional 
Advocacy Ellen Rathfon, the AAPA puts 
a high priority on building relationships 
with other leading medical organiza-
tions. Wright, she added, was chosen to 
represent AAPA, and the P.A. profession 
as a whole, raising the profile of collab-
orative team-based care with physicians 
and other national medical groups.
“I see this as an opportunity to 
advance the strategic plans of both the 
AAPA and NAMME,” said Wright, whose 
term begins July 1, 2017. “In order to 
achieve this goal, strategic partnerships 
between academic institutions, constit-
uent organizations, and community 
stakeholders are paramount. Serving as 
medical liaison between the AAPA and 
NAMME will help advance this goal.”  
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CLASS NOTES
1960s 
Vincent T. Devita Jr., M.D. ’61, HON. 
’84, received the 2017 Yale Cancer 
Center Lifetime Achievement Award. 
David Henry Goodman, M.D. ’63, was 
named Clinical Professor Emeritus by 
the Department of Medicine at George 
Washington University School of 
Medicine and Health Sciences. 
1970s 
Paul B. Roth, M.D. ’76, FACEP, was 
awarded the New Mexico Spirit of 
Achievement Award by National 
Jewish Health. 
John Joseph Wells, M.D. ’78, was 
awarded Top Doc in Phoenix magazine. 
1980s 
Andrea Carpenter, M.D. ’89, Ph.D., 
served as president of the Southern 
Thoracic Surgical Association in 2016. 
Robert C. Hendel, M.D. ’83, was 
appointed as the Sidney W. and Marilyn S. 
Lassen Chair in Cardiovascular Medicine, 
chief, Section of Cardiology, director of 
Tulane Heart and Vascular Institute. 
Peter Kaufman, M.D. ’80, was 
named Fellow of the American 
Gastroenterology Association and also 
named a Washingtonian Top Doc for 
the second year. 
James Longobardi, D.P.M., M.B.A., 
P.A. ’80, was elected chief of surgery, 
Mercy Scripps Chula Vista, 2017–19. 
1990s 
Nathaniel Beers, M.D. ’95, CERT 
’04, FAAP, assumed the role of CEO 
of the HSC Health Care System, a 
nonprofit health care organization in 
Washington, D.C., in May 2017. In this 
role, he oversees the HSC Pediatric 
Center, both inpatient and outpa-
tient services, HSC Home Care and 
residential services, health services for 
children with special health care needs, 
the Medicaid managed care provider 
for children and youth with disabilities 
in D.C., and the HSC Foundation.  
Kendalle Cobb, M.D. ’96, received the 
Chief of Staff Award from the Cleveland 
Clinic. The $25,000 grant will be used to 
explore the challenges and successes 
the Cleveland Clinic faces in creating a 
culture of diversity and inclusion. 
Erin Hogan, B.S. ’98, Emergency 
Medical Services, was promoted 
to philanthropic market executive, 
Southeast U.S., U.S. Trust, Bank of 
America Private Wealth Management. 
Oscar I. Dodek Jr., M.D. ’56, J.D. ’85, 
Professor Emeritus of Obstetrics and 
Gynecology at the George Washington 
University (GW) School of Medicine and 
Health Sciences (SMHS), died March 2, 2017. 
A native Washingtonian, Dodek had a 
lengthy career as a physician special-
izing in reproductive endocrinology. At 
SMHS, he served as a clinical professor of 
obstetrics and gynecology for 35 years 
and became Professor Emeritus in 1998. 
He was the first board-certified reproduc-
tive endocrinologist in the Washington, 
D.C., area, and specialized in the latest 
techniques to combat infertility. In 1978, 
Dodek established the Division of Reproductive Endocrinology at GW. 
Dodek earned his M.D. degree from GW in 1956. He completed his residency 
training in obstetrics and gynecology at Mount Sinai Medical Center and served a 
fellowship at the Worcester Foundation for Experimental Biology. In 1985, Dodek 
graduated from GW Law School and became a member of the Order of the Coif, 
an honor society for United States law graduates.
Dodek had many civic and philanthropic interests and was a passionate advocate 
for human rights and women’s issues. The Kane-King-Dodek Obstetrical Honor 
Society was established to recognize the leaders in the department of obstetrics 
and gynecology at GW. The Oscar I. Dodek and Mildred S. Dodek and Joan B. and 
Oscar I. Dodek Jr., M.D. ’56, J.D. ’85, professorship, established in 1982, has been 
held by a notable list of SMHS leaders, including the current Dodek Professor and 
Chair, Nancy D. Gaba, M.D. ’93, RESD ’97, FACOG, who was installed Oct. 8, 2014.
Elizabeth Ann Ignacio, M.D., 
RESD ’98, served as president of the 
Hawaii Radiological Society, state 
chapter of American College of 
Radiology, 2016–17. 
John G. Pattaras, M.D. ’92, RESD ’99, 
associate professor of urology at 
Emory University School of Medicine, 
was named Emory’s James C. Kennedy 
Chair in Prostate Surgery. He is also 
the chief of Emory urology services at 
Saint Joseph’s Hospital and director of 




James C. Bruce, M.D. ’51, RESD ’55 
Arnold L. Case, M.D. ’60 
William Chin-Lee, M.D. ’47 
William S. Costello, CERT ’95 
Paul R. Dinsmore, M.D. ’58 
Morris Feitel, M.D. ’57 
Lynn D. George, M.D. ’56, B.A. ’53 
Walter E. Goozh, M.D. ’57, B.A. ’54 
Stephen B. Hiltabidle, M.D. ’55, RESD ’59 
Frank Mate Jr., M.D. ’56 
John G. McGregor Jr., M.D. ’53 
Mazhar Rishi, M.D., RESD ’90 
John Norton Robinson, M.D. ’63 
Dennis D. Shepard, M.D. ’63 
Harold H. Shively, M.D. ’65 
Nelson P. Trujillo, M.D., RESD ’65 
A. James Watt, M.D. ’71 
Emily Wilson, P.A.-C. ’91 
Edgar Ratilla, CERT ’95, Health Science 
Laboratory Technology, obtained the 
American Society for Quality’s certi-
fied manager of quality/organizational 
excellence designation. 
John S. Symington, M.D., RESD ’91, 
became president of the INOVA Mt. 
Vernon Hospital staff. 
2000s 
Petros Carvounis, M.D., RESD ’05, was 
recognized as a Top Doctor in ophthal-
mology in Houstonia magazine. 
Brett F. Holt, M.D. ’06, RESD ’08, 
was featured in the International 
Association of Health Care 
Professionals urologist publication The 
Leading Physicians of the World. Holt is 
a board-certified urologist specializing 
in urinary tract disease and the male 
reproductive system, and is a robotic 
surgery expert. 
Hope T. Jackson, M.D. ’09, RESD ’16, 
CERT ’14, minimally invasive surgery 
foregut/bariatric surgery fellow at 
the University of Washington Medical 
Center, was selected as one of the 2017 
National Minority Quality Forum 40 
Under 40 Leaders in Minority Health. 
Supriya Jagannath-Vanguri, M.D. 
’02, B.A. ’98, serves as an oral board 
examiner for the American Board of 
Anesthesiology. 
Lt. Commander Ian Marks, P.A. ’00, 
CERT ’00, graduated from the United 
States Naval War College in the fall of 
2016. He is the first Coast Guard physi-
cian assistant to earn a diploma from 
the Naval War College and is currently 
serving as the senior medical officer 
for the U.S.C.G. clinic in the port of 
Los Angeles. 
Thomas Maruna, B.S. ’09, A.A. ’06, 
CERT ’05, Clinical Laboratory Sciences, 
received the Junior Officer Medical 
Laboratory Scientist of the Year 
Award from the United States Public 
Health Service. 
Louis Miller, M.D. ’03, B.A. ’99, 
received the New York University 
Department of Medicine Teacher of the 
Year award. 
Lauryn Rochlen, M.D. ’04, was selected 
to serve as a board examiner for the 
American Board of Anesthesiology. 
Jaspal Singh, M.D. ’06, B.A. ’02, was 
named co-director of the recently 
opened Weill Cornell Medicine Center 
for Comprehensive Spine Care in 
New York City. Singh also serves as 
the medical director of outpatient 
faculty practice in the Department of 
Rehabilitation Medicine at Weill Cornell 
Medical College. 
Jennifer M. Stonebrook, M.S. ’09, 
Health Sciences, earned certification as 
a hospice and palliative care adminis-
trator through the Canadian Hospice 
Palliative Care Association. 
2010s 
Megan Evans, M.D. ’11, was appointed 
assistant professor at Tufts Medical 
School and associate program director 
of the Tufts OB/GYN residency program. 
Pooja Lakshmin, M.D., RESD ’16, 
joined the faculty of the George 
Washington University School of 
Medicine and Health Sciences 
Department of Psychiatry and 
Behavioral Sciences as an assistant 
professor. She specializes in repro-
ductive psychiatry and women’s 
mental health. 
Sarah R. Miller, D.P.T. ’11, was named 
as a fellow at the American Academy of 
Orthopedic Manual Physical Therapy. 
Grace A. Montenegro, M.D., RESD 
’11, earned board certification from 
the American Board of Colon and 
Rectal Surgery. 
Resmi Premji, M.D., FEL ’16, recently 
earned board certification in endocri-
nology, diabetes, and metabolism. 
Jean L. Fourcroy-Behr, M.D., Ph.D., 
RESD ’79, M.P.H., died in October 
2016. Fourcroy-Behr was the first 
woman admitted to the George 
Washington University School of 
Medicine and Health Sciences 
urology residency program. In 1981, 
Fourcroy-Behr became only the fifth 
woman in the country to earn board 
certification in urology. 
In 2013, in recognition of her fierce 
determination and her guidance as 
a role model for women entering the 
field of urology, SMHS established 
the Jean L. Fourcroy-Behr, M.D., 
Research Award, thanks to a gen-
erous gift from Fourcroy-Behr and 
her husband Armin Behr. 
“I hope it will encourage more resi-
dents to take an interest in research, 
and more faculty and others to be 
supportive,” said Fourcroy-Behr at 
the time.
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cholarships for our 
medical and health 
sciences students 
remain our most 
important priority for 
fundraising as we close out 
the fiscal year on June 30. 
Our Adopt-a-Doc scholar-
ship donors have expressed 
personal satisfaction from 
giving through the program 
because it offers them an 
opportunity to connect with 
their sponsored students. 
The Adopt-a-Doc program 
provides $5,000 per year over 
four years through an annual 
pledge payment, which helps 
make a small, but mean-
ingful, dent in the debt load 
upon graduation. 
Students in the physician assistant, physical therapy, and other health 
sciences programs face similar debt challenges. We are committed to alleviating 
their burdens as well.
Any of our development officers can discuss our programs with you, and 
you can find information on our website: smhs.gwu.edu/give. We invite you to 
look into it.
Already this year, the George Washington University School of Medicine 
and Health Sciences (SMHS) has benefited from larger contributions to the 
Power & Promise scholarship fund, which provides aid to students with 
financial need. This spring, we received a nearly half-million-dollar bequest 
from the estate of a grateful alumnus. Gifts of all sizes and the income generated 
by endowed funds are the lifeblood of our scholarship program. We are very 
grateful to the generous GW donors who have joined us in the effort to help 
SMHS students graduate with less debt, and we invite everyone to join this 
important cause.
Sincerely, 
Dennis Narango, M.A., CFRE
Associate Dean, SMHS and Associate Vice President for  
GW Medicine Development and Alumni Relations
If you are 70 ½ or older, you can take advantage of a simple way to benefit the GW School 
of Medicine and Health Sciences and receive tax benefits in return. You can give up to 
$100,000 annually from your IRA directly to SMHS without having to pay income taxes 
on the money. These gifts count toward your IRA’s minimum distribution requirements 
and benefit you regardless of whether you itemize deductions on your income tax returns. 
Visit gwu.planmylegacy.org/ira-charitable-rollover for more information.
IN DEVELOPMENT Board of Advisors
Lara S. Oboler, M.D. ’95, Chair 
Cardiology; Lenox Hill Heart & Vascular Institute
Gary M. Abramson 
Partner, the Tower Companies
Christopher L. Barley, M.D. ’93 
Internal Medicine; Clinical Assistant Professor of 
Medicine, Cornell/Weill School of Medicine
Constance Urciolo Battle, M.D. ’67, FAAP 
Pediatrics and Public Health
Luther W. Brady Jr., M.D. ’48, HON. ’04, B.A. ’46, 
A.A. ’44 
Radiation Oncology; Affiliated Faculty, Department 
of Radiation Oncology, Drexel University College of 
Medicine; GW Emeritus Trustee
Elizabeth L. Cobbs, M.D. ’81, RESD ’84 
Professor of Medicine, GW School of Medicine and 
Health Sciences; Chief, Department of Geriatrics, 
Extended Care, and Palliative Care, GW Medical 
Faculty Associates
Carlos R. Diaz, M.D. ’72, RESD ’75 
President and Owner, Aeromedical Services
Daniel Ein, M.D., FACP, FAAAAI, FACAAI 
Allergy, Asthma, and Immunology; Clinical Professor 
of Medicine, GW School of Medicine and Health 
Sciences; Director, Allergy & Sinus Center, GW 
Medical Faculty Associates
Thomas E. Flynn, M.D. ’86 
Ophthalmology; Ellsworth Uveitis & Retina Care
Jeanne G. Holzgrefe, M.D. ’96, Ph.D., M.P.H. 
Psychiatry; Chevy Chase Psychiatric Services; 
Assistant Clinical Professor of Psychiatry and 
Behavioral Sciences, GW School of Medicine and 
Health Sciences
Floyd Alexander Katske, M.D. ’76, RESD ’77 
Urology; Clinical Assistant Professor of Urology, 
David Geffen School of Medicine, UCLA
Kerry L. Kuhn, M.D. ’73, RESD ’77, B.A. ’70, FACOG 
Obstetrics and Gynecology; Private Practice; Senior 
Vice President of VitalMD
Gerald S. Lazarus, M.D. ’63 
Dermatology; Professor of Dermatology, Johns 
Hopkins University; Former Member, GW Board 
of Trustees
John C. Pan, M.D. ’70, RESD ’74 
Obstetrics and Gynecology; Founder, Center for 
Integrative Medicine, GW School of Medicine and 
Health Sciences
Smita H. Patel, M.D., DFAPA 
Psychiatry; Assistant Clinical Professor of Psychiatry 
and Behavioral Science, GW School of Medicine and 
Health Sciences
Rakesh C. Sahni, M.D. 
Cardiology; Maryland Cardiology Associates
Mark W. Surrey, M.D. ’72, FACOG, FACS 
Obstetrics and Gynecology and Reproductive 
Endocrinology; Professor and Clinical Director, 
Reproductive Surgery, UCLA; Co-Founder and 
Medical Director, Southern California Reproductive 
Center
The SMHS Board of Advisors offers the dean of the School of Medicine 
and Health Sciences recommendations on strategic priorities and impor-
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Cultivating Strengths Within Health Sciences
Senior Associate Dean for Health Sciences Reamer L. Bushardt, Pharm.D., P.A.-C., DFAAPA, discusses how his background and 
experiences — from growing up as the son of a pharmacist in a quiet South Carolina community to his years as professor and 
chair of the Department of Physician Assistant Studies at Wake Forest Baptist Medical Center’s School of Medicine — will shape 
his efforts to support the health sciences programs at GW. Read more on page 12.
